Arcutis Biotherapeutics Inc (ARQT)
EBITDA
$43.43M
TTM · Period ending: · USD
ARQT EBITDA
Latest reported$43.43Mperiod ending
Latest reported$43.43Mperiod ending
ARQT TTM EBITDA ($21.00K → $43.43M)
TTM EBITDA
High-resolution chart · PNG
ARQT ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 43,429,000 | |
| 14,328,000 | |
| 1,933,000 | |
| -23,952,000 | |
| -68,688,000 | |
| -101,567,000 | |
| -110,120,000 | |
| -163,776,000 | |
| -163,959,000 | |
| -182,384,000 | |
| -227,859,000 | |
| -234,504,000 | |
| -303,236,000 | |
| -305,231,000 | |
| -294,872,000 | |
| -301,305,000 | |
| -255,641,000 | |
| -232,294,000 | |
| -205,902,000 | |
| -168,741,000 | |
| -150,150,000 | |
| -143,628,000 | |
| -135,670,000 | |
| -114,058,000 | |
| -90,414,000 | |
| -63,569,000 | |
| -42,511,000 | |
| -30,094,000 | |
| -15,445,000 | |
| -6,907,500 | |
| 21,000 |